What is the dosage of Genvoya?

Genvoya is available in 1 dosages, including 150-150-200-10 mg Tab

What does Genvoya treat?

Genvoya treats HIV Infections and Chronic Hepatitis B

What is Genvoya made of?

Genvoya contains cobicistat / elvitegravir / emtricitabine / tenofovir alafenamide which is a Cytochrome P450 3A Inhibitor

How is Genvoya administered?

Genvoya is administered as a Oral Pill

What is Genvoya mechanism of action?

Genvoya mechanism of action is Breast Cancer Resistance Protein Inhibitors, Cytochrome P450 2C9 Inducers, Cytochrome P450 2D6 Inhibitors, Cytochrome P450 3A Inhibitors, HIV Integrase Inhibitors, Nucleoside Reverse Transcriptase Inhibitors, Organic Anion Transporting Polypeptide 1B1 Inhibitors, Organic Anion Transporting Polypeptide 1B3 Inhibitors or P-Glycoprotein Inhibitors

Dosage & Administration Drug label Prior authorization Financial assistance

Patient education

Genvoya

(cobicistat / elvitegravir / emtricitabine / tenofovir alafenamide)

cobicistat 150 MG / elvitegravir 150 MG / emtricitabine 200 MG / tenofovir alafenamide 10 MG Oral Tablet [Genvoya]

BLACK BOX WARNING

Dosage & administration

* Testing: Prior to or when initiating GENVOYA test for hepatitis B virus infection. Prior to or when initiating GENVOYA, and during treatment on a clinically appropriate schedule, assess serum creatinine, estimated creatinine clearance, urine glucose, and urine protein in all patients. In patients with chronic kidney disease, also assess serum phosphorus.
* Recommended dosage in adult and pediatric patients weighing at least 25 kg: One tablet taken orally once daily with food in patients with body weight at least 25 kg and a creatinine clearance greater than or equal to 30 mL per minute, or in adult patients with creatinine clearance less than 15 mL per minute who are receiving chronic hemodialysis. On days of hemodialysis, administer GENVOYA after hemodialysis.
* Renal impairment: GENVOYA is not recommended in patients with estimated creatinine clearance of 15 to below 30 mL per minute, or below 15 mL per minute who are not receiving chronic hemodialysis.
* Hepatic impairment: GENVOYA is not recommended in patients with severe hepatic impairment.

drug label

Genvoya prescribing information

Have more Genvoya questions?

Submit MSL Request

Learn More

Need to report a Genvoya issue?

ONLINE FORMReport adverse event

Learn More

prior authorization

Genvoya Prior authorization resources

NOT PROVIDED BY BRANDComplete Letter of Medical Necessity

NOT PROVIDED BY BRANDCoverage Authorization Request

NOT PROVIDED BY BRANDCoverage Authorization Appeals

Learn More

Benefits investigation

NOT PROVIDED BY BRANDBenefits investigation resources

Learn More

Reimbursement help (FRM)

NOT PROVIDED BY BRANDReimbursement help (FRM) resources

Learn More

financial assistance

Genvoya Financial assistance options

Co-pay savings program

commercial only

Enroll in Patient Savings Program

Activate Co-Pay Card (if already have one)

Replace Co-Pay card (if lost one)

Learn More

Overview

Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)

Patient benefit

A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max

Patient eligibility

Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
May never be used with government insurance

How to sign up

Cards may be downloadable digital cards or hard copies
Some pharmacos offer debit cards with pre-loaded copay benefit
Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form

Bridge program

commercial only

Learn More

Overview

Provide patient immediate access to therapy during an insurance delay (typically new starts; some may cover change in insurance)
Limited time/ fill (typically 7-30 days; some may offer additional fill for continued delay up to certain limit)

Patient benefit

100% free (outside of insurance)

Patient eligibility

HCP must enroll patient
May be limited to commercially insured patients (i.e., no government beneficiaries); some programs may allow government beneficiaries

How to sign up

Typically HCP assisted enrollment (via form)

Foundation programs

under insured

no insurance

goverment insurance

65+

Patient Assistance Program

Learn More

Overview

Charitable 501(c)(3) organizations provide direct cost-sharing and other support (e.g., travel, counseling) through disease-state funds to indigent patients on first-come first-served basis
These organizations may receive financial contributions from drug manaufacturers for particular disease-state funds that cannot provide funds directly to patients - the foundation must be independent/unaligned

Patient benefit

Patients apply for grants that cover a portion (or all) of their out-of-pocket costs (deductibles and co-pays) until the grant is exhausted

Patient eligibility

Patients must apply and meet eligibility criteria including income level (typically a multiple of federal poverty line), specific diagnosis, insurance status, etc.

How to sign up

Patients submit proof of out-of-pocket drug costs to charities for reimbursement

patient education

Genvoya Patient education

Getting started on Genvoya

NOT PROVIDED BY BRANDInstructions For Use: HIV

Patient toolkit

Genvoya Tear Sheet

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

Learn More

Genvoya FAQs

FAQ Data Source

Can't find what you're looking for?

Our trained staff can help you:

Please note:

Access to a Field Reimbursement Manager (FRM) or Medical Science Liaison (MSL) varies by brand and may require talking with your rep first.
Samples are provided at the discretion of the brand.
We are unable to collect Protected Health Information (PHI), fill out forms, or submit them on your behalf.

Genvoya

Dosage & administration

drug label

Genvoya prescribing information

Have more Genvoya questions?

Need to report a Genvoya issue?

prior authorization

Genvoya Prior authorization resources

Benefits investigation

Reimbursement help (FRM)

financial assistance

Genvoya Financial assistance options

Co-pay savings program

Bridge program

Foundation programs

patient education

Genvoya Patient education

Getting started on Genvoya

Patient toolkit

people also ask

Genvoya FAQs

Can't find what you're looking for?